Effect of everolimus on polycystic liver volume in autosomal dominant polycystic kidney disease

被引:2
作者
Zschiedrich, Stefan [1 ]
Budde, Klemens [2 ]
Walz, Gerd [1 ]
机构
[1] Univ Hosp Freiburg, Div Renal, Dept Med, D-79106 Freiburg, Germany
[2] Charite, Div Renal, D-10117 Berlin, Germany
关键词
ADPKD; Liver cysts; Everolimus; Treatment;
D O I
10.1007/s10157-014-1059-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:757 / 758
页数:2
相关论文
共 4 条
  • [1] The long-term outcome of patients with polycystic liver disease treated with lanreotide
    Chrispijn, M.
    Nevens, F.
    Gevers, T. J. G.
    Vanslembrouck, R.
    van Oijen, M. G. H.
    Coudyzer, W.
    Hoffmann, A. L.
    Dekker, H. M.
    de Man, R. A.
    van Keimpema, L.
    Drenth, J. P. H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) : 266 - 274
  • [2] Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: Results from a randomized controlled trial
    Chrispijn, Melissa
    Gevers, Tom J. G.
    Hol, Jeroen C.
    Monshouwer, Rene
    Dekker, Heleen M.
    Drenth, Joost P. H.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 153 - 159
  • [3] Sirolimus reduces polycystic liver volume in ADPKD patients
    Qian, Qi
    Du, Hui
    King, Bernard F.
    Kumar, Sumedha
    Dean, Patrick G.
    Cosio, Fernando G.
    Torres, Vicente E.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (03): : 631 - 638
  • [4] Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
    Walz, Gerd
    Budde, Klemens
    Mannaa, Marwan
    Nuernberger, Jens
    Wanner, Christoph
    Sommerer, Claudia
    Kunzendorf, Ulrich
    Banas, Bernhard
    Hoerl, Walter H.
    Obermueller, Nicholas
    Arns, Wolfgang
    Pavenstaedt, Hermann
    Gaedeke, Jens
    Buechert, Martin
    May, Christoph
    Gschaidmeier, Harald
    Kramer, Stefan
    Eckardt, Kai-Uwe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) : 830 - 840